50mg/5ml injectable solution

 Each ampoule contains 50 mg Atracurium besylate.

Pharmacologic category:

Nondepolarizing neuromuscular blocker

Indication and administration:

• An adjunct to general anesthesia, to facilitate endotracheal intubation
• to provide skeletal muscle relaxation during surgery or mechanical ventilation

Intravenous injection and infusion only; should not be mixed in the same syringe, or administered simultaneously through the same needle, with alkaline solutions.